ATE432287T1 - Peptidfragmente mit den zelltod verhindernder aktivität - Google Patents
Peptidfragmente mit den zelltod verhindernder aktivitätInfo
- Publication number
- ATE432287T1 ATE432287T1 AT99972642T AT99972642T ATE432287T1 AT E432287 T1 ATE432287 T1 AT E432287T1 AT 99972642 T AT99972642 T AT 99972642T AT 99972642 T AT99972642 T AT 99972642T AT E432287 T1 ATE432287 T1 AT E432287T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide fragments
- amino acid
- series
- cell death
- peptide
- Prior art date
Links
- 108010033276 Peptide Fragments Proteins 0.000 title abstract 11
- 102000007079 Peptide Fragments Human genes 0.000 title abstract 11
- 230000030833 cell death Effects 0.000 title 1
- 230000003405 preventing effect Effects 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 125000000539 amino acid group Chemical group 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 102000004531 Selenoprotein P Human genes 0.000 abstract 1
- 108010042443 Selenoprotein P Proteins 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34786398 | 1998-11-19 | ||
| PCT/JP1999/006322 WO2000031131A1 (fr) | 1998-11-19 | 1999-11-12 | Fragments peptidiques a activite inhibitrice de la mort cellulaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE432287T1 true ATE432287T1 (de) | 2009-06-15 |
Family
ID=18393115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99972642T ATE432287T1 (de) | 1998-11-19 | 1999-11-12 | Peptidfragmente mit den zelltod verhindernder aktivität |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7199097B1 (de) |
| EP (1) | EP1132402B1 (de) |
| JP (1) | JP4485062B2 (de) |
| AT (1) | ATE432287T1 (de) |
| AU (1) | AU1179500A (de) |
| CA (1) | CA2351558C (de) |
| DE (1) | DE69940927D1 (de) |
| WO (1) | WO2000031131A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002067976A1 (fr) * | 2001-02-28 | 2002-09-06 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Nouveaux inhibiteurs de lesion d'ischemie/reperfusion |
| US20050037954A1 (en) * | 2001-03-23 | 2005-02-17 | Masaki Hirashima | Novel agents for ameliorating motor disorder |
| JPWO2002076493A1 (ja) * | 2001-03-23 | 2004-10-14 | 財団法人化学及血清療法研究所 | 新規な免疫異常性疾患予防・治療用薬剤 |
| WO2002092121A1 (fr) | 2001-05-11 | 2002-11-21 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Nouveaux remedes pour maladies neurodegeneratives |
| US7960508B2 (en) * | 2001-05-11 | 2011-06-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Peptide having cytotoxicity inhibitory activity and method of screening these peptide having cytotoxicity inhibitory activity |
| EP1393078B1 (de) * | 2001-05-16 | 2009-07-08 | Xavier Forceville | Verfahren für die in-vitro-diagnostik oder für die überwachung einer krankheit mit entzündungsreaktion |
| JP2003026598A (ja) * | 2001-06-27 | 2003-01-29 | Chemo Sero Therapeut Res Inst | 新規なリウマチ予防・治療用薬剤 |
| WO2003016347A1 (fr) * | 2001-08-09 | 2003-02-27 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Procede de preparation d'un fragment peptidique presentant une activite inhibitrice de mort cellulaire |
| JP2004182616A (ja) * | 2002-11-29 | 2004-07-02 | Chemo Sero Therapeut Res Inst | 新規な神経伝達機能異常疾患改善剤 |
| WO2008122039A2 (en) | 2007-04-02 | 2008-10-09 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Selenocysteine mediated hybrid antibody molecules |
| JP6370637B2 (ja) * | 2013-08-27 | 2018-08-08 | 学校法人同志社 | ２型糖尿病の治療及び／又は予防薬 |
| CA3094966A1 (en) | 2018-03-29 | 2019-10-03 | Airway Therapeutics, Inc. | Systems and methods for characterizing surfactant protein d (sp-d) oligomers |
| CN114907445B (zh) * | 2022-05-10 | 2023-06-06 | 华南农业大学 | 一种高抗氧化活性富硒肽及其应用 |
-
1999
- 1999-11-12 JP JP2000583957A patent/JP4485062B2/ja not_active Expired - Fee Related
- 1999-11-12 AU AU11795/00A patent/AU1179500A/en not_active Abandoned
- 1999-11-12 AT AT99972642T patent/ATE432287T1/de active
- 1999-11-12 DE DE69940927T patent/DE69940927D1/de not_active Expired - Lifetime
- 1999-11-12 US US09/856,199 patent/US7199097B1/en not_active Expired - Fee Related
- 1999-11-12 EP EP99972642A patent/EP1132402B1/de not_active Expired - Lifetime
- 1999-11-12 CA CA002351558A patent/CA2351558C/en not_active Expired - Fee Related
- 1999-11-12 WO PCT/JP1999/006322 patent/WO2000031131A1/ja not_active Ceased
-
2005
- 2005-07-21 US US11/185,859 patent/US7598349B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4485062B2 (ja) | 2010-06-16 |
| DE69940927D1 (de) | 2009-07-09 |
| AU1179500A (en) | 2000-06-13 |
| CA2351558A1 (en) | 2000-06-02 |
| CA2351558C (en) | 2010-01-12 |
| WO2000031131A1 (fr) | 2000-06-02 |
| US7598349B2 (en) | 2009-10-06 |
| EP1132402B1 (de) | 2009-05-27 |
| US20050281808A1 (en) | 2005-12-22 |
| EP1132402A4 (de) | 2005-12-21 |
| EP1132402A1 (de) | 2001-09-12 |
| US7199097B1 (en) | 2007-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE368053T1 (de) | Antimikrobielle peptide | |
| KR970702917A (ko) | Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체 | |
| DK150992A (da) | Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor | |
| ATE295414T1 (de) | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen | |
| ATE269902T1 (de) | Cytokinähnliches polypeptid-10 aus säugetieren | |
| ATE432287T1 (de) | Peptidfragmente mit den zelltod verhindernder aktivität | |
| ATE168719T1 (de) | Osteogene peptide | |
| DK156592D0 (da) | Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin | |
| DE69840509D1 (de) | Apoptose-bezogene verbindungen und deren verwendung | |
| ATE408685T1 (de) | Antimikrobielle peptide, abstammend von ubiquicidin | |
| DE60313982D1 (de) | Dimere von thrombinpeptidderivaten | |
| DE69432427D1 (de) | Tomate xyloglukan endotransglykosylase | |
| DE69607034D1 (de) | Pcna bindende substanz | |
| ATE374246T1 (de) | Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter | |
| TR200003498T2 (tr) | Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları | |
| DE60234843D1 (de) | Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten | |
| EA200100314A1 (ru) | Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины | |
| DE60138885D1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
| DE69827880D1 (de) | Iga1-protease fragment als trägerpeptid | |
| ATE328897T1 (de) | Verwendung von hev-polypeptiden | |
| DK1158050T3 (da) | Human cysteinyl-leukotrienreceptor (CysLT2) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1132402 Country of ref document: EP |